Table 2 Table showing multiplicity and axillary lymph nodes status by the different imaging modalities in upfront surgery group
Multiplicity | Multiplicity | Count | % |
Sono-mammography | Single | 15/37 | 40.5% |
Multiple | 15/37 | 40.5% | |
No | 7/37 | 18.9% | |
DCE-MRI | Single | 19/37 | 51.4% |
Multiple | 17/37 | 45.9% | |
No | 1/37 | 2.7% | |
Postoperative pathology | Single | 24/37 | 64.9% |
Multiple | 12/37 | 32.4% | |
No | 1/37 | 2.7% | |
Lymph nodes | LN status | Count | % |
SM AXLNs | Pathological | 16/37 | 43.2% |
Non specific | 21/37 | 56.8% | |
SM other LNs | Pathological | 1/37 | 2.7% |
IMLN | 1/37 | 2.7% | |
DCE-MRI AXLNs | Pathological | 19/37 | 51.4% |
Non specific | 18/37 | 48.6% | |
DCE-MRI other LNs | Pathological | 1/37 | 2.7% |
IMLNs | 4/37 | 10.8% | |
DWI-MRI LNs | Pathological | 13/37 | 35.1% |
Non specific | 24/37 | 64.9% | |
Postoperative pathology AXLNs | Pathological | 15/37 | 40.5% |
Non specific | 22/37 | 59.4% |